ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

UCSF and ClearPoint Neuro announce partnership to develop an innovative cellular delivery platform from the lab of Dr. Daniel Lim, MD, PhD via an exclusive multi-year licensing agreement. Bringing together UCSF's technology with the ClearPoint system will enable precise and targeted therapeutic delivery.